Karus Therapeutics Ltd.

Scroll
Investment area
Novo Ventures
Region
Europe
Date of investment
June 2012
Website
http://www.karustherapeutics.com/

Karus Therapeutics develops innovative therapies for the treatment of inflammation and cancer. The lead programmes are in pre-clinical development and focus on histone deacetylase and phosphoinositide 3-kinase inhibitors.

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more